Calprotectin quantified with the MRP8/14 ELISA was numerically elevated in the CD and UC patients with moderate disease activity compared with patients in remission based on the SES-CD score (remission IQR: [264, 156-349], mild IQR: [304, 250-380], moderate IQR: [318, 271-483], severe IQR: [218, 122-289]) and Full Mayo score (remission IQR: [326, 202-436], mild IQR: [315, 143-586], moderate IQR: [342, 248-586], severe IQR: [247, 234-544]), although the difference did not reach statistical significance [ Figure 4C and F ].
← all excerpts
A Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity.
1
—
—